The opportunistic pathogen Clostridium perfringens possesses the ability to colonize the protective mucin layer in the gastrointestinal tract. To assist this, the C. perfringens genome contains a battery of genes encoding glycoside hydrolases (GHs) that are likely active on mucin glycans, including four genes encoding family 84 GHs: CpGH84A (NagH), CpGH84B (NagI), CpGH84C (NagJ) and CpGH84D (NagK). To probe the potential advantage gained by the expansion of GH84 enzymes in C. perfringens, we undertook the structural and functional characterization of the CpGH84 catalytic modules. Here, we show that these four CpGH84 catalytic modules act as β-N-acetyl-D-glucosaminidases able to hydrolyze N- and O-glycan motifs. CpGH84A and CpGH84D displayed a substrate specificity restricted to terminal β-1,2- and β-1,6-linked N-acetyl-D-glucosamine (GlcNAc). CpGH84B and CpGH84C appear more promiscuous with activity on terminal β-1,2-, β-1,3- and β-1,6-linked GlcNAc; both possess some activity toward β-1,4-linked GlcNAc, but this is dependent upon which monosaccharide it is linked to. Furthermore, all the CpGH84s have different optimum pHs ranging from 5.2 to 7.0. Consistent with their β-N-acetyl-D-glucosaminidase activities, the structures of the four catalytic modules revealed similar folds with a catalytic site including a conserved −1 subsite that binds GlcNAc. However, nonconserved residues in the vicinity of the +1 subsite suggest different accommodation of the sugar preceding the terminal GlcNAc, resulting in subtly different substrate specificities. This structure–function comparison of the four GH84 catalytic modules from C. perfringens reveals their different biochemical properties, which may relate to how they are deployed in the bacterium’s niche in the host.
14 August 2009 in Organic & Biomolecular Chemistry
The synthesis of amino-derivatives of castanospermine and australine and their characterisation as inhibitors of the exo-β-D-glucosaminidase CsxA through enzyme kinetics and X-ray structural analysis is described.
13 October 2016 in British Journal of Pharmacology
Background and Purpose: The arylamineN‐acetyltransferases (NATs) are xenobiotic‐metabolizing enzymes that play an important role in the detoxification and/or bioactivation of arylamine drugs and xenobiotics. In bacteria, NATs may contribute to the resistance against antibiotics such as isoniazid or sulfamides through their acetylation, which makes this enzyme family a possible drug target.Bacillus anthracis, a bacterial species of clinical significance, expresses three NAT isozymes with distinct structural and enzymatic properties, including an inactive isozyme ((BACAN)NAT3). (BACAN)NAT3 features both a non‐canonical Glu residue in its catalytic triad and a truncated C‐terminus domain. However, the role these unusual characteristics play in the lack of activity of the (BACAN)NAT3 isozyme remains unclear.Experimental Approach: Protein engineering, recombinant expression, enzymatic analyses with aromatic amine substrates and phylogenetic analysis approaches were conducted.Key Results: The deletion of guanine 580 (G580) in thenat3gene was shown to be responsible for the expression of a truncated (BACAN)NAT3 isozyme. Artificial re‐introduction of G580 in thenat3gene led to a functional enzyme able to acetylate several arylamine drugs displaying structural characteristics comparable with its functionalBacillus cereushomologue ((BACCR)NAT3). Phylogenetic analysis of thenat3gene in theB. cereusgroup further indicated thatnat3may constitute a pseudogene of theB. anthracisspecies.Conclusion and Implications: The existence of NATs with distinct properties and evolution inBacillusspecies may account for their adaptation to their diverse chemical environments. A better understanding of these isozymes is of importance for their possible use as drug targets.LINKED ARTICLES: This article is part of a themed section on Drug Metabolism and Antibiotic Resistance in Micro‐organisms. To view the other articles in this section visithttp://onlinelibrary.wiley.com/doi/10.1111/bph.v174.14/issuetoc
19 August 2020 in Acta Crystallographica Section F Structural Biology Communications